Elevated CRP and ESR: Clinical Significance and Diagnostic Approach

Introduction to Inflammatory Markers

Elevated C-Reactive Protein (CRP) and Erythrocyte Sedimentation Rate (ESR) indicate the presence of inflammation in the body, which can be caused by various conditions including infections, autoimmune disorders, malignancies, and tissue damage 1, 2

Normal ESR values are typically <20 mm/h in men and <30 mm/h in women, with values increasing with age 3
CRP values >10 mg/L have traditionally been considered indicative of significant inflammation, though this cutoff may exclude individuals with chronic low-grade inflammation 4, 5

Moderate ESR elevation (50-100 mm/h) suggests significant underlying disease, while values >100 mm/h have high specificity (92.2%) for conditions like giant cell arteritis 3

In inflammatory bowel disease (IBD), CRP correlates better with endoscopic disease activity in Crohn's disease than in ulcerative colitis 2
In rheumatoid arthritis, both markers are included in disease activity scores (DAS28, SDAI) and help monitor treatment response 6
In suspected prosthetic joint infections, CRP has a sensitivity of 73-91% and specificity of 81-86% when a cutoff of 13.5 mg/L is used 7
In multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2, elevated inflammatory markers including CRP and ESR are part of the diagnostic criteria 8

Laboratory evaluation should include full blood count, electrolytes, liver enzymes, serum albumin, and renal function tests to assess for underlying causes and disease severity 1, 2
Infectious causes should be ruled out with appropriate blood and stool cultures, particularly Clostridium difficile and Cytomegalovirus in suspected IBD flares 2
Cross-sectional imaging (CT, MRI, ultrasound) may be necessary to detect complications such as abscesses or fistulae in conditions like IBD 2
Consider factors that may artificially elevate ESR, including anemia, female sex, and advanced age 3

Biologic agents targeting specific inflammatory cytokines may disproportionately affect ESR or CRP levels, potentially masking disease activity 6
Regular monitoring of both markers is recommended for conditions like giant cell arteritis, polymyalgia rheumatica, and certain inflammatory disorders to assess treatment response 3